[  1] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  2] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  3] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  4] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  5] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  6] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  7] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[  8] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  9] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 10] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 11] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 12] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 13] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 14] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 15] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 16] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 17] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 18] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 19] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 20] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 21] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 22] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 23] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 24] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 25] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 26] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 27] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 28] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 29] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 30] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 31] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 32] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 33] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 34] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 35] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 36] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 37] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 38] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 39] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 40] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 41] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 42] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 43] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 44] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 45] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 46] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 47] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 48] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 49] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 50] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 51] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 52] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 53] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 54] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 55] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 56] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 57] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 58] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 59] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 60] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 61] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 62] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 63] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 64] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 65] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 66] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 67] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[ 68] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 69] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 70] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 71] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 72] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 73] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 74] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 75] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 76] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 77] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 78] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 79] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[ 80] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 81] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 82] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 83] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 84] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 85] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 86] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[ 87] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 88] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 89] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 90] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 91] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[ 92] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 93] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 94] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 95] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 96] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[ 97] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[ 98] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 99] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[100] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[101] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[102] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[103] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[104] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[105] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[106] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[107] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[108] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[109] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[110] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[111] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[112] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[113] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[114] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[115] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[116] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[117] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[118] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[119] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[120] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[121] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[122] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[123] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[124] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[125] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[126] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[127] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[128] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[129] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[130] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[131] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[132] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[133] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[134] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[135] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[136] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[137] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[138] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[139] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[140] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[141] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[142] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[143] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[144] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[145] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[146] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[147] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[148] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[149] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[150] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[151] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[152] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[153] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[154] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[155] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[156] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[157] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[158] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[159] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[160] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[161] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[162] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[163] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[164] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[165] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[166] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[167] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[168] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[169] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[170] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[171] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[172] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[173] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[174] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[175] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[176] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[177] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[178] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[179] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[180] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[181] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[182] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[183] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[184] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[185] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[186] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[187] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[188] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[189] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[190] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[191] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[192] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[193] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[194] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[195] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[196] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[197] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[198] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[199] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[200] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[201] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[202] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[203] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[204] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[205] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[206] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[207] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[208] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[209] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[210] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[211] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[212] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[213] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[214] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[215] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[216] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[217] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[218] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[219] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[220] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[221] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[222] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[223] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[224] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[225] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[226] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[227] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[228] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[229] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[230] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[231] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[232] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[233] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[234] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[235] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[236] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[237] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[238] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[239] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[240] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[241] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[242] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[243] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[244] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[245] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[246] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[247] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[248] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[249] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[250] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[251] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[252] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[253] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[254] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[255] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[256] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[257] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[258] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[259] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[260] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[261] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[262] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[263] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[264] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[265] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[266] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[267] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[268] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[269] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[270] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[271] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[272] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[273] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[274] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[275] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[276] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[277] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[278] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[279] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[280] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[281] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[282] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[283] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[284] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[285] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[286] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[287] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[288] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[289] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[290] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[291] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[292] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[293] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[294] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[295] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[296] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[297] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[298] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[299] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[300] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[301] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[302] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[303] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[304] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[305] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[306] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[307] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[308] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[309] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[310] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[311] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[312] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[313] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[314] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[315] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[316] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[317] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[318] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[319] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[320] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[321] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[322] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[323] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[324] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[325] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[326] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[327] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[328] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[329] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[330] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[331] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[332] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[333] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[334] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[335] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[336] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[337] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[338] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[339] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[340] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[341] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[342] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[343] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[344] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[345] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[346] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[347] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[348] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[349] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[350] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[351] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[352] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[353] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[354] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[355] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[356] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[357] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[358] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[359] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[360] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[361] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[362] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[363] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[364] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[365] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[366] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[367] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[368] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[369] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[370] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[371] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[372] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[373] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[374] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[375] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[376] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[377] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[378] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[379] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[380] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[381] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[382] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[383] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[384] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[385] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[386] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[387] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[388] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[389] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[390] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[391] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[392] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[393] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[394] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[395] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[396] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[397] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[398] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[399] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[400] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[401] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[402] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[403] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[404] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[405] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[406] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[407] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[408] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[409] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[410] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[411] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[412] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[413] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[414] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[415] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[416] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[417] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[418] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[419] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[420] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[421] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[422] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[423] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[424] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[425] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[426] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[427] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[428] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[429] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[430] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[431] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[432] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[433] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[434] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[435] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[436] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[437] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[438] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[439] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[440] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[441] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[442] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[443] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[444] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[445] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[446] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[447] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[448] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[449] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[450] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[451] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[452] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[453] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[454] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[455] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[456] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[457] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[458] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[459] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[460] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[461] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[462] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[463] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[464] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[465] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[466] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[467] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[468] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[469] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[470] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[471] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[472] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[473] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[474] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[475] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[476] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[477] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[478] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[479] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[480] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[481] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[482] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[483] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[484] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[485] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[486] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[487] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[488] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[489] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[490] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[491] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[492] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[493] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[494] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[495] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[496] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[497] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[498] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[499] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[500] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[501] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[502] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[503] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[504] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[505] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[506] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[507] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[508] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[509] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[510] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[511] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[512] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[513] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[514] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[515] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[516] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[517] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[518] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[519] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[520] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[521] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[522] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[523] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[524] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[525] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[526] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[527] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[528] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[529] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[530] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[531] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[532] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[533] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[534] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[535] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[536] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[537] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[538] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[539] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[540] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[541] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[542] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[543] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[544] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[545] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[546] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[547] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[548] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[549] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[550] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[551] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[552] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[553] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[554] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[555] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[556] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[557] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[558] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[559] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[560] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[561] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[562] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[563] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[564] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[565] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[566] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[567] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[568] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[569] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[570] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[571] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[572] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[573] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[574] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[575] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[576] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[577] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[578] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[579] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[580] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[581] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[582] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[583] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[584] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[585] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[586] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[587] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[588] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[589] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[590] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[591] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[592] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[593] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[594] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[595] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[596] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[597] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[598] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[599] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[600] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[601] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[602] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[603] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[604] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[605] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[606] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[607] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[608] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[609] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[610] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[611] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[612] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[613] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[614] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[615] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[616] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[617] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[618] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[619] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[620] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[621] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[622] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[623] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[624] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[625] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[626] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[627] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[628] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[629] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[630] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[631] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[632] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[633] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[634] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[635] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[636] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[637] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[638] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[639] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[640] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[641] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[642] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[643] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[644] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[645] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[646] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[647] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[648] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[649] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[650] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[651] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[652] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[653] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[654] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[655] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[656] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[657] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[658] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[659] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[660] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[661] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[662] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[663] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[664] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[665] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[666] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[667] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[668] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[669] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[670] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[671] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[672] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[673] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[674] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[675] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[676] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[677] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[678] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[679] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[680] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[681] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[682] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[683] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[684] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[685] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[686] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[687] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[688] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[689] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[690] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[691] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[692] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[693] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[694] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[695] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[696] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[697] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[698] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[699] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[700] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[701] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[702] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[703] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[704] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[705] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[706] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[707] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[708] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[709] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[710] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[711] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[712] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[713] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[714] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[715] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[716] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[717] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[718] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[719] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[720] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[721] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[722] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[723] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[724] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[725] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[726] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[727] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[728] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[729] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[730] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[731] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[732] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[733] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[734] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[735] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[736] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[737] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[738] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[739] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[740] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[741] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[742] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[743] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[744] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[745] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[746] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[747] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[748] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[749] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[750] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[751] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[752] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[753] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[754] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[755] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[756] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[757] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[758] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[759] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[760] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[761] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[762] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[763] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[764] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[765] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[766] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[767] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[768] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[769] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[770] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[771] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[772] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[773] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[774] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[775] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[776] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[777] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[778] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[779] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[780] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[781] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[782] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[783] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[784] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[785] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[786] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[787] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[788] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[789] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[790] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[791] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[792] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[793] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[794] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[795] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[796] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[797] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[798] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[799] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[800] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[801] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[802] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[803] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[804] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[805] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[806] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[807] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[808] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[809] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[810] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[811] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[812] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[813] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[814] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[815] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[816] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[817] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[818] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[819] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[820] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[821] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[822] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[823] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[824] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[825] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[826] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[827] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[828] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[829] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[830] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[831] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[832] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[833] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[834] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[835] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[836] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[837] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[838] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[839] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[840] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[841] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[842] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[843] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[844] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[845] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[846] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[847] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[848] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[849] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[850] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[851] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[852] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[853] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[854] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[855] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[856] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[857] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[858] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[859] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[860] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[861] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[862] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[863] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[864] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[865] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[866] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[867] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[868] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[869] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[870] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[871] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[872] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[873] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[874] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[875] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[876] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[877] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[878] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[879] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[880] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[881] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[882] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[883] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[884] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[885] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[886] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[887] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[888] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[889] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[890] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[891] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[892] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[893] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[894] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[895] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[896] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[897] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[898] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[899] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[900] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[901] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[902] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[903] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[904] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[905] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[906] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[907] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[908] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[909] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[910] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[911] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[912] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[913] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[914] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[915] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[916] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[917] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[918] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[919] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[920] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[921] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[922] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[923] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[924] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[925] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[926] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[927] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[928] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[929] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[930] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[931] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[932] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[933] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[934] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[935] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[936] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[937] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[938] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[939] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[940] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[941] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[942] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[943] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[944] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[945] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[946] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[947] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[948] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[949] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[950] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[951] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[952] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[953] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[954] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[955] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[956] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[957] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[958] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[959] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[960] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[961] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[962] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[963] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[964] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[965] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[966] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[967] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[968] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[969] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[970] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[971] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[972] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[973] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[974] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[975] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[976] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[977] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[978] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[979] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[980] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[981] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[982] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[983] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[984] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[985] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[986] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[987] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[988] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[989] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[990] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[991] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[992] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[993] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[994] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[995] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[996] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[997] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[998] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[999] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1000] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1001] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1002] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1003] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1004] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1005] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1006] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1007] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1008] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1009] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[1010] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[1011] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1012] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1013] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1014] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1015] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1016] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1017] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1018] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1019] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1020] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1021] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1022] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1023] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1024] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1025] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1026] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1027] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1028] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1029] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1030] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1031] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1032] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1033] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1034] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[1035] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1036] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[1037] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[1038] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[1039] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[1040] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1041] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1042] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1043] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1044] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1045] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1046] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1047] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1048] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1049] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1050] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1051] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[1052] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[1053] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1054] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1055] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1056] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1057] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1058] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1059] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1060] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1061] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1062] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1063] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1064] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1065] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1066] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1067] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1068] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1069] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1070] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1071] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-10)/Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.
[1072] Analysts/Institutional Investor Meet/Con. Call Updates (2025-05-17)/Morepen Laboratories Limited has informed the Exchange about Transcript
[1073] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1074] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1075] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Orchid Pharma Limited has informed the Exchange about Transcript
[1076] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[1077] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1078] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[1079] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-04)/Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript
[1080] Analysts/Institutional Investor Meet/Con. Call Updates (2026-01-27)/Jagsonpal Pharmaceuticals Limited has informed the Exchange about Transcript
[1081] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[1082] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1083] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1084] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1085] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1086] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1087] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[1088] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1089] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1090] Press Release (2026-02-06)/Solara Active Pharma Sciences Limited has informed the exchange regarding the press release dated February 06, 2026, titled "Solara Q3'26 Performance."
[1091] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[1092] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1093] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[1094] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-06)/Rubicon Research Limited has informed the Exchange about Transcript
[1095] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1096] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[1097] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1098] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1099] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1100] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[1101] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[1102] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1103] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1104] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1105] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[1106] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026